MINNEAPOLIS, July 21, 2011 /PRNewswire/ — Uroplasty, Inc.
(NASDAQ:
UPI) announced today that it will release financial results for
the first quarter of fiscal 2012 ended June 30, 2011, at the market
close on Thursday, July 28, 2011. The Company will host a
conference call to discuss these results on Thursday, July 28, 2011
at 4:30 p.m. Eastern Time (3:30 p.m. Central Time). David Kaysen,
President and Chief Executive Officer, and Medi Jiwani, Vice
President, Chief Financial Officer and Treasurer, will host the
call. Individuals wishing to participate in the conference
call should dial 877-941-8609. An audio replay will be available
for 30 days following the call at 800-406-7325 (domestic) and
303-590-3030 (international), with the passcode 4455479#.
About Uroplasty, Inc.Uroplasty, Inc., headquartered in
Minnetonka, Minnesota, with wholly-owned subsidiaries in the
Netherlands and the United Kingdom, is a medical device company
that develops, manufactures and markets innovative proprietary
products for the treatment of voiding dysfunctions. Our focus
is the continued commercialization of our Urgent PC Neuromodulation
System, which we believe is the only FDA-cleared minimally
invasive, office-based neuromodulation therapy for the treatment of
overactive bladder and the associated symptoms of urinary urgency,
urinary frequency and urge incontinence.
We also offer Macroplastique Implants, an injectable urethral
bulking agent for the treatment of adult female stress urinary
incontinence primarily due to intrinsic sphincter deficiency.
For more information on the company and its products, please
visit Uroplasty, Inc. at www.uroplasty.com. For Further
Information:Uroplasty, Inc.
David Kaysen, President and CEO, or
Medi Jiwani, Vice President, CFO, Treasurer
952.426.6140 EVC Group
‘/>”/>
SOURCE
